Adimmune Corporation (TPE:4142)
18.50
-0.20 (-1.07%)
Apr 17, 2026, 1:30 PM CST
Adimmune Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,186 | 2,345 | 2,458 | 2,857 | 2,652 |
Short-Term Investments | 31 | 112.5 | 12.5 | 100.5 | 239 |
Trading Asset Securities | 0.47 | - | - | - | - |
Cash & Short-Term Investments | 2,218 | 2,457 | 2,470 | 2,958 | 2,891 |
Cash Growth | -9.73% | -0.52% | -16.49% | 2.30% | -34.66% |
Accounts Receivable | 146.86 | 187.81 | 1,308 | 534.97 | 99.64 |
Other Receivables | 38.63 | 39.76 | 30.51 | 43.09 | 111.22 |
Receivables | 185.5 | 227.57 | 1,339 | 578.06 | 210.86 |
Inventory | 692.91 | 764.59 | 682.33 | 815.94 | 602.1 |
Prepaid Expenses | 6.44 | 6.45 | 8.19 | 4.42 | 4 |
Other Current Assets | 168.31 | 154.27 | 200.21 | 135.34 | 88.02 |
Total Current Assets | 3,271 | 3,610 | 4,699 | 4,491 | 3,796 |
Property, Plant & Equipment | 4,015 | 3,818 | 3,613 | 3,641 | 3,447 |
Long-Term Investments | 91.64 | 109.66 | 105.86 | 100.25 | 119.34 |
Other Intangible Assets | 17.9 | 34.46 | 51.11 | 67.98 | 85.82 |
Long-Term Accounts Receivable | 334.93 | 334.93 | 334.93 | 326.66 | 137.37 |
Long-Term Deferred Tax Assets | 227.26 | 227.42 | 227.6 | 227.59 | 228.03 |
Long-Term Deferred Charges | 7.45 | 13.4 | 19.36 | 25.32 | 31.27 |
Other Long-Term Assets | 227.8 | 333.93 | 433.57 | 268.29 | 165.53 |
Total Assets | 8,193 | 8,481 | 9,484 | 9,149 | 8,010 |
Accounts Payable | 17.04 | 31.25 | 42.35 | 48.84 | 5.88 |
Accrued Expenses | 198.41 | 195.15 | 126.85 | 192.83 | 145.77 |
Short-Term Debt | 325 | 500 | 540 | 20 | - |
Current Portion of Long-Term Debt | 890.8 | 320.04 | 669.93 | 125.01 | 41.09 |
Current Portion of Leases | 20.62 | 19.02 | 14.71 | 16.68 | 7.13 |
Current Unearned Revenue | 35.45 | 9.39 | 21.81 | 11.11 | 23.44 |
Other Current Liabilities | 58.53 | 86.46 | 371.3 | 86.02 | 73.73 |
Total Current Liabilities | 1,546 | 1,161 | 1,787 | 500.49 | 297.04 |
Long-Term Debt | 1,548 | 1,705 | 1,869 | 2,039 | 1,266 |
Long-Term Leases | 45.91 | 52.33 | 48.71 | 61.65 | 6.34 |
Other Long-Term Liabilities | 1.25 | 0.84 | 1.94 | 2.35 | 7.95 |
Total Liabilities | 3,141 | 2,920 | 3,707 | 2,604 | 1,578 |
Common Stock | 4,295 | 4,295 | 4,295 | 4,295 | 4,295 |
Additional Paid-In Capital | 829.5 | 829.5 | 835.41 | 849.05 | 855.12 |
Retained Earnings | 86.12 | 351.19 | 597.61 | 1,238 | 944.84 |
Treasury Stock | -292.54 | -292.54 | -292.54 | -292.54 | - |
Comprehensive Income & Other | 26.24 | 49.49 | 38.94 | 34.62 | 53.79 |
Total Common Equity | 4,944 | 5,233 | 5,475 | 6,124 | 6,149 |
Minority Interest | 107.32 | 328.97 | 303.07 | 421.07 | 283.72 |
Shareholders' Equity | 5,052 | 5,562 | 5,778 | 6,545 | 6,433 |
Total Liabilities & Equity | 8,193 | 8,481 | 9,484 | 9,149 | 8,010 |
Total Debt | 2,830 | 2,597 | 3,143 | 2,263 | 1,321 |
Net Cash (Debt) | -612.29 | -139.56 | -672.63 | 695.03 | 1,570 |
Net Cash Growth | - | - | - | -55.74% | -49.36% |
Net Cash Per Share | -1.45 | -0.33 | -1.60 | 1.63 | 3.66 |
Filing Date Shares Outstanding | 421.51 | 421.51 | 421.51 | 421.51 | 429.51 |
Total Common Shares Outstanding | 421.51 | 421.51 | 421.51 | 421.51 | 429.51 |
Working Capital | 1,725 | 2,449 | 2,912 | 3,991 | 3,499 |
Book Value Per Share | 11.73 | 12.41 | 12.99 | 14.53 | 14.32 |
Tangible Book Value | 4,926 | 5,198 | 5,423 | 6,056 | 6,063 |
Tangible Book Value Per Share | 11.69 | 12.33 | 12.87 | 14.37 | 14.12 |
Land | 14.36 | 14.36 | 14.36 | 14.36 | 14.36 |
Buildings | 2,148 | 2,143 | 2,138 | 2,117 | 2,108 |
Machinery | 2,319 | 2,319 | 2,332 | 2,255 | 1,999 |
Construction In Progress | 1,718 | 1,379 | 1,029 | 1,100 | 1,032 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.